Free Trial

Globeflex Capital L P Purchases Shares of 38,270 Viemed Healthcare, Inc. (NASDAQ:VMD)

Viemed Healthcare logo with Medical background
Remove Ads

Globeflex Capital L P acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 38,270 shares of the company's stock, valued at approximately $307,000. Globeflex Capital L P owned about 0.10% of Viemed Healthcare at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Wasatch Advisors LP lifted its stake in shares of Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company's stock worth $13,552,000 after buying an additional 303,277 shares during the last quarter. Rice Hall James & Associates LLC acquired a new position in Viemed Healthcare during the 4th quarter worth $2,083,000. First Eagle Investment Management LLC lifted its position in Viemed Healthcare by 196.5% during the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock worth $2,637,000 after acquiring an additional 217,923 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in Viemed Healthcare by 748.2% during the third quarter. Victory Capital Management Inc. now owns 108,497 shares of the company's stock valued at $795,000 after acquiring an additional 95,706 shares during the period. Finally, JPMorgan Chase & Co. grew its position in shares of Viemed Healthcare by 151.7% in the third quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company's stock valued at $724,000 after purchasing an additional 59,538 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD traded down $0.22 during trading hours on Thursday, hitting $7.36. 70,740 shares of the company's stock were exchanged, compared to its average volume of 133,751. The company's 50-day moving average price is $7.94 and its 200-day moving average price is $8.20. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $9.81. The stock has a market capitalization of $290.88 million, a price-to-earnings ratio of 27.26 and a beta of 1.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Remove Ads

Viemed Healthcare Profile

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Stories

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

Should You Invest $1,000 in Viemed Healthcare Right Now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads